EZH2与BRD4-NUT合作,通过抑制关键瘤抑制基因来驱动NUT癌症的生长
Yeying Huang1, R Taylor Durall1, Nhi M Luong1
1Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Cancer research
|September 25, 2023
概括
抑制EZH2,一种基因沉默蛋白,显示出治疗NUT癌的前景. 结合EZH2和BET抑制剂,协同阻断瘤生长,并在临床前模型中改善存活率.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 瘤癌是由BRD4-NUT融合蛋白驱动的,导致瘤的侵袭性生长.
- 作为NUT癌的单一疗法,BET代酶抑制剂 (BETi) 的疗效有限.
- 增强性基因同源2 (EZH2) 被确定为NUT癌症的关键依赖性,负责基因沉默.
研究的目的:
- 为了研究EZH2在NUT癌症中的作用.
- 评估EZH2抑制的疗效,单独或与BET抑制剂结合,用于NUT癌症治疗.
主要方法:
- 使用临床化合物tazemetostat来抑制EZH2.2.
- 进行了表观遗传和转录组分析,以评估分子变化.
- 进行了CRISPR-Cas9查,以确定抵抗机制.
- 在临床前NUT癌症模型中测试了EZH2和BET联合抑制.
主要成果:
- 塔泽米托斯塔特通过逆转EZH2-介导的基因沉默,强烈抑制了NUT癌细胞的生长.
- 鉴定出CDKN2A是一种由EZH2抑制的关键瘤抑制基因,并赋予了对tazemetostat的耐药性.
- 联合EZH2和BET抑制显示出协同效应,导致明显的瘤生长停止和分化.
- 在临床前模型中,联合治疗显著阻断了瘤生长和延长了生存时间,在某些情况下观察到完全缓解.
结论:
- EZH2是NUT癌症的关键依赖,突出了对瘤生长的表观遗传失调的依赖.
- 结合EZH2和BET抑制剂,通过向互补的表观遗传通路,为NUT癌症提供了一个有前途的治疗策略.
- 通过EZH2抑制CDKN2A等瘤抑制基因,为组合疗法提供了强大的机制基础.
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Hedgehog Signaling Pathway
7.4K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


